BIO Asia–Taiwan 2022 亞洲生技大會

BIO Asia–Taiwan 2022 亞洲生技大會

講師

中華海洋生技股份有限公司

 

Company Info

Name /Hi-Q Marine Biotech International Ltd

Address /No123-1, Sec.4 Bade Rd., Songshan Dist., Taipei, Taiwan.

Website /www.fucoidanhiq.com

Presenter

Name /Kenny Su

Title /Director of Market Development Dept.

Email /kennysu@hiqbio.com

Telephone /+886-2-27470006 #195

Fax /+886-932-174337

Mobile /+886-2-27470030

Company Type

Biotechnology

About the Company

Hi-Q Marine Biotech is founded in 1998, a leading marine biotechnology company in Taiwan. Hi-Q specializes in the research and development of Low Molecular Weight Fucoidan (Oligo Fucoidan), a type of clinically-proven ingredient extracted from natural brown seaweed, developed specifically for nutritional, cosmetic and animal health applications. With the passion of ‘empowering people to lead healthier lives’, Hi-Q are investing in development of cancer nutrition to fulfill the ongoing need to proper and adjunct nutrition to cancer patients as they suffer from cachexia. In addition to the own expert teams, Hi-Q collaborates with leading research institutions for advanced research and solution.

Brief Description of main products or services

Fucoidan is a kind of polysaccharide substance which mainly exists in the surface mucus of brown seaweed (kelp). Hi-Q developed the advance hydrolysis technology to extract the bioactive Low Molecular Weight Fucoidan (Oligo Fucoidan) from brown seaweed. Oligo Fucoidan is verified by scientific studies and human clinical trials in multi health benefits. With an excellent R&D team, more than 50 international scientific articles were published. Among the articles, over 30 explore carcinogenesis, immunomodulation and inflammation. In a prospective, randomized, double-blind, controlled clinical trial in patients with metastatic colorectal cancer (mCRC), using Low Molecular Weight Fucoidan as an adjunct treatment with anti-cancer drugs significantly improved disease control rate (DCR). Proper nutrition is a vital factor in enhancing the effectiveness of cancer treatment and provide benefits to cancer cachectic patients. Oligo Fucoidan is a kind of clinically-proven ingredient used as a nutritional adjunct for cancer patients, provides nutritional therapies to improve the quality of life. Hi-Q has continued scientific studies and human clinical trials of Oligo Fucoidan since 2008. It is marketed under the tradename OLIFUCO®. Oligo Fucoidan also has attained its inclusion in the Dictionary of Drugs of the U.S. National Cancer Institute (NCI) (Code C170752).

Contact Person

Name /Belle Lin

Email /bellelin@hiqbio.com

Phone /+886-2-27470006#193